AbCellera to Report Full Year 2022 Financial Results on February 21, 2023
25 January 2023 - 8:05AM
Business Wire
AbCellera (Nasdaq: ABCL) will announce its full year 2022
financial results on Tuesday, February 21, 2023, and hold an
earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m.
Eastern Time) the same day.
A live audio webcast of the earnings conference may be accessed
through a link that will be posted on AbCellera’s Investor
Relations website. A replay will be available through the same link
following the conference call.
About AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and
analyzes natural immune systems to find antibodies that its
partners can develop into drugs to prevent and treat disease.
AbCellera partners with drug developers of all sizes, from large
pharmaceutical to small biotechnology companies, empowering them to
move quickly, reduce cost, and tackle the toughest problems in drug
development. For more information, please visit
www.abcellera.com.
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230123005747/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Murray
McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Josephine Hellschlienger Ph.D.; ir@abcellera.com,
+1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Apr 2023 to Apr 2024